BOULBoule Diagnostics AB (publ)
3.250SEK-0.91%Mkt Cap: 12.07M $P/E:

Boule Diagnostics AB (publ) develops, manufactures, and markets instruments and consumable products for blood diagnostics in the United States of America, Asia, Eastern Europe, Latin America, Western Europe, Africa, and …

Key Statistics

Company
Market Cap12.07M $
Enterprise Value32.05M $
Revenue (TTM)44.12M $
Gross Profit20.45M $
Net Income (TTM)-358.98K $
Revenue/Share1.244 USD
Last Price3.250 SEK
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees200
CountrySE
SectorHealthcare
IndustryMedical Devices
ISIN
Valuation
P/E (Trailing)
P/E (Forward)2.90
PEG
EV/EBITDA15.47
EV/Revenue0.73
P/S0.28
P/B0.73
EPS (TTM)-0.14
EPS (Forward)1.13
52W Range
2.75013% of range6.640
52W High6.640 SEK
52W Low2.750 SEK
Profitability
Gross Margin43.66%
Oper. Margin2.94%
EBITDA Margin4.69%
Profit Margin-0.77%
ROE-2.24%
ROA-0.80%
Growth
Revenue Growth-13.20%
Earnings Growth
Cash Flow & Leverage
Operating CF79.30K $
CapEx (TTM)474.72K $
FCF Margin0.21%
FCF Yield0.78%
Net Debt19.87M $
Net Debt/EBITDA9.59
Balance Sheet
Debt/Equity1.33
Current Ratio1.07
Quick Ratio0.68
Book Value/Sh4.504 SEK
Cash/Share0.5050 SEK
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 SEK
Div. Yield
5Y Avg Yield0.73%
Payout Ratio0.00%
Ex-Div DateMay 6, 2022
Pay Date
Splits
Last Split4:1
Split DateJun 1, 2018
Analyst Consensus
Rating
Target (Mean)3.800 SEK
Upside (mean)+16.9%
Target Range3.800 SEK3.800 SEK
# Analysts1
Ownership
Shares Out.38.83M
Float22.80M
Insiders35.31%
Institutions54.43%
Technical
SMA 503.583 (-9.3%)
SMA 2004.253 (-23.6%)
Beta0.18
S&P 52W Chg18.16%
Avg Vol (30d)35.11K
Avg Vol (10d)19.47K
Technical Indicators
RSI (14)39.0
MACD-0.0754
MACD Signal-0.0316
MACD Hist.-0.0438
BB Upper3.907 SEK
BB Middle3.554 SEK
BB Lower3.200 SEK
BB Width19.90%
ATR (14)0.2255 SEK
Vol Ratio (20d)0.10x